[email protected]19 Aug, 2021News
Riding on huge investor interest in the healthcare sector, five pharma companies are tapping the initial public offering (IPO) market over the next couple of weeks to raise over Rs 8,000 crore. The list include the Rs 4,000-crore IPO by the Bain Capital-backed Emcure Pharma, the Rs 1,500-crore issue by Vijaya Diagnostic Centre, diagnostic firms Krsnaa Diagnostics (Rs 1,200 crore) and Mumbai-based bulk drugs maker Supriya Lifesciences (Rs 1,200 crore), and pharma formulations contract development and manufacturer (CDMO) Windlass Biotech's Rs 400 crore issue.
Big88 Yachts
Lc88
98win Bet
North Idaho Trimlight
Jessie Roa
Green Qween Weed Dispensary West Hollywood
Rosedale Plumbing
Boston Airport Transportation
Pelactiv
850bet Brasil Cassino Online